Fortrea Holdings Inc. filings document the public-company disclosures of a Nasdaq-listed contract research organization. The company’s 8-K reports furnish operating results and financial condition updates, including revenue, profitability measures, book-to-bill metrics, guidance and related press release exhibits.
Fortrea’s regulatory filings also cover proxy governance, annual meeting matters, board composition, executive compensation and inducement award plans. Capital-structure disclosures include common stock, rights to purchase Series A preferred stock, senior secured notes activity and other debt or equity matters tied to the company’s clinical development services business.
Fortrea Holdings Inc. reported the results of its 2026 Annual Meeting of Stockholders held on June 9, 2026. As of the April 15, 2026 record date, 94,584,730 common shares were outstanding, and 86,194,966 shares were present or represented by proxy, establishing a quorum.
Stockholders elected Anshul Thakral, Peter M. Neupert and William J. Sharbaugh to the board. They ratified Deloitte & Touche LLP as independent registered public accounting firm for the year ending December 31, 2026, and approved on an advisory basis the compensation of the Company’s named executive officers.
Mark A. Morais, identified as an officer of Fortrea Holdings Inc. (FTRE), proposes to sell 4,674 common shares; the approximate sale date is June 10, 2026, and the listed aggregate market value is $78,640.05. Fidelity Brokerage Services LLC is listed as the broker.
The shares are listed as acquired through restricted stock vesting: 1,598 shares on February 7, 2024, and 3,076 shares on March 13, 2025. The notice also lists three sales during the past three months: 4,599 shares for $41,717.07 on March 10, 2026; 1,804 shares for $16,627.29 on March 16, 2026; and 4,866 shares for $75,364.61 on June 2, 2026.
Fortrea Holdings Inc. Chief Operating Officer Mark A. Morais reported routine equity compensation activity and related tax sales. He exercised 11,006 Restricted Stock Units into the same number of Common Stock shares at a conversion price of $0.00, reflecting scheduled vesting tied to the company’s equity plans and a prior spin-off arrangement.
To fund tax withholding on this vesting, he sold 4,866 Common Stock shares in an open-market “sell to cover” transaction at a weighted average price of $15.49, with trades executed between $15.04 and $15.69. The filing states these sales were mandated by the issuer and were not discretionary trades. After these transactions, Morais directly holds 76,039 Common Stock shares, indirectly holds 4,625 shares through his spouse, and holds 101,995 RSUs.
Fortrea Holdings Inc. Chief Financial Officer Jill G. Mcconnell converted 11,006 Restricted Stock Units into an equal number of common shares on June 1, 2026 as part of scheduled vesting tied to the Labcorp spin-off. The next day, she sold 4,866 shares at a weighted average price of $15.49 solely to cover tax withholding obligations under Fortrea’s equity incentive plans, which require "sell to cover" transactions rather than discretionary sales. After these transactions, she directly holds 78,416 shares of common stock and 140,841 RSUs in total.
Fortrea Holdings Inc. officer Jill G. McConnell reported a proposed sale of 4,866 common shares, with an approximate sale date of June 2, 2026 and an aggregate market value of $75,364.61. Fidelity Brokerage Services LLC is named as the broker. McConnell acquired the shares from the issuer on June 1, 2026 through restricted stock vesting as compensation; the sale includes an amount necessary to cover a tax obligation resulting from settlement of a vested equity award distribution. She also reported sales of 5,061 shares for gross proceeds of $45,907.82 on March 10, 2026, and 1,804 shares for $16,627.29 on March 16, 2026.
Fortrea Holdings Inc. officer Mark A. Morais reported a planned sale of 4,866 common shares, with an approximate sale date of June 2, 2026, and an aggregate market value of $75,364.61. Morais acquired 4,866 shares through restricted stock vesting on June 1, 2026, as compensation. The reported sale includes an amount necessary to cover a tax obligation resulting from settlement of a vested equity award distribution.
Fortrea Holdings Inc. Chief Accounting Officer Robert Parks sold 2,000 shares of Common Stock in an open-market transaction at $13.44 per share. After this sale, he directly holds 20,389 shares of Fortrea common stock. The filing describes this as a straightforward sale by the reporting person, with no derivatives involved.
Fortrea Holdings Inc. director Peter M. Neupert reported a routine equity compensation event. On May 14, 2026, he settled 148,536 Restricted Stock Units into the same number of shares of Fortrea common stock on their scheduled vesting date. Following this vesting and conversion, he holds an aggregate of 246,668 shares of common stock directly. The filing reflects an exercise/conversion of RSUs rather than an open-market purchase or sale.
Fortrea Holdings Inc. (FTRE) officer Robert A. Parks reported plans to sell 2,000 common shares, with an approximate sale date of May 18, 2026, and an aggregate market value of $26,870.00. The notice lists 94,600,000 common shares outstanding. The shares were acquired through restricted stock vesting: 1,450 shares on September 6, 2025, and 550 shares on September 13, 2025. Parks also reported selling 1,927 common shares on March 10, 2026, for gross proceeds of $17,479.62.